Eric Curtis's Net Worth
$1.11 Thousand
Who is Eric Curtis?
Eric Curtis does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include WINDTREE THERAPEUTICS INC /DE/, CYTRX CORP, and Aegerion Pharmaceuticals, Inc..
SEC CIK
Eric Curtis's CIK is 0001651755
Past Insider Trading and Trends
2020 was Eric Curtis's most active year for acquiring shares with 2 total transactions. Eric Curtis's most active month to acquire stocks was the month of February. 2023 was Eric Curtis's most active year for disposing of shares, totalling 1 transactions. Eric Curtis's most active month to dispose stocks was the month of January. 2020 saw Eric Curtis paying a total of $2,635.00 for 205,961 shares, this is the most they've acquired in one year. In 2023 Eric Curtis cashed out on 99 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
WINDTREE THERAPEUTICS INC /DE/ (WINT) Snapshot price: $0.36
SVP & COOEric Curtis owns 15,920 units of Common Stock which is worth $5,731.20. From 2020 to 2023 Eric Curtis acquired a total of 82,258 shares in WINDTREE THERAPEUTICS INC /DE/ at a cost of $4,626.11, Eric also disposed a total of 99 shares of WINDTREE THERAPEUTICS INC /DE/.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,170.55% | 14.67K |
—
|
—
| 15.92K |
Aug 23
| |||
Form 4
| -7.32% | -99.00 |
—
|
—
| 1.25K |
Feb 28
| |||
Form 4
| +5,135.55% | 66.3K |
—
|
—
| 67.59K |
Mar 4
| |||
Form 4
| +158.20% | 791 |
$2.52 | $1,991.11 | 1.29K |
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 4
|
∞
| 500 |
$5.27 | $2,635.00 | 500 |
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CYTRX CORP (LADX) Snapshot price: $1.9
Pres., Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aegerion Pharmaceuticals, Inc. No price found
President, U.S. Commercial
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||